CYP27A1 and chronic kidney disease: The mean 1,25-(OH)2D3 levels in the CKD group was significantly lower than in the control group, while mean serum levels of CTX, a bone resorption marker [28], were significantly higher in the CKD group than in the control and PTX+CKD groups.